Ethos Biosciences Revenue and Competitors
Estimated Revenue & Valuation
- Ethos Biosciences's estimated annual revenue is currently $5.1M per year.
- Ethos Biosciences's estimated revenue per employee is $155,000
Employee Data
- Ethos Biosciences has 33 Employees.
- Ethos Biosciences grew their employee count by 18% last year.
Ethos Biosciences's People
Name | Title | Email/Phone |
---|---|---|
1 | Office Operations Manager | Reveal Email/Phone |
2 | President | Reveal Email/Phone |
Ethos Biosciences Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.6M | 10 | 0% | N/A | N/A |
#2 | $4M | 26 | 13% | N/A | N/A |
#3 | $0.9M | 6 | -14% | N/A | N/A |
#4 | $1.1M | 7 | 0% | N/A | N/A |
#5 | $10.9M | 70 | 3% | N/A | N/A |
#6 | $0.7M | 9 | 29% | N/A | N/A |
#7 | $4M | 26 | -16% | N/A | N/A |
#8 | $1.7M | 11 | 22% | N/A | N/A |
#9 | $7.6M | 49 | 2% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Ethos Biosciences?
Ethos Biosciences designs, develops, and manufactures assays that are accurate, repeatable, and easy to use. Our vision is to provide gold standard assays for novel biomarkers to institutions pioneering biomedical research. Ethos Biosciences was formed as a subsidiary of Ott Scientific in 2018 to drive healthcare innovation by providing diagnostic tools for scientists and practitioners. In November 2018, Ethos Biosciences acquired the Exocell diagnostic operation in Philadelphia from Glycadia Pharmaceuticals. Exocell was founded in 1988 by Dr. Margo Cohen, MD/PhD to explore diagnostic and therapeutic solutions for diabetes. Exocell quickly became a leader in nephrology diagnostics with 15 patents and over 2000 research citations. The Exocell brand continues to service the top research, academic, and industrial institutions in the world. Ott Scientific is a family owned and operated group of specialty chemical manufacturing companies with expertise in monomers, polymers, microspheres, and reagents for the pharmaceutical, medical device, and diagnostic industries.
keywords:N/AN/A
Total Funding
33
Number of Employees
$5.1M
Revenue (est)
18%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $2.6M | 33 | -41% | $230M |
#2 | $5.4M | 33 | 3% | N/A |
#3 | $3.8M | 33 | N/A | N/A |
#4 | $3.8M | 33 | N/A | N/A |
#5 | $5.4M | 33 | 10% | N/A |